ALSO NOTED: Novartis may hand out cancer drug in Thailand; Abilify gets new use against major depression;

> Novartis may give Thailand free cancer meds if the country lays off its fight to compel drug makers to license generic versions of patented remedies. Report

> Bristol-Myers Squibb's antipsychotic med Abilify got the FDA's nod as an add-on therapy for major depression in patients who don't respond fully to antidepressants alone. Report

> Datamonitor predicts that sales of the Bayer/Onyx drug Nexavar will be "substantially boosted" by its new U.S. approval for treatment of inoperable liver cancer. Report

> Canadian students are abusing prescription painkillers at an unprecedented rate, according to a new survey. Report

And Finally... Need more evidence that stress can be a killer? The stress hormone norepinephrine appear to stimulate tumor-cell growth. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.